2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes N of 1 Trials - Diabetes, Cardiovascular Disease | Phase 4 | Terminated | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 6 | 2006-09-01 | 2008-01-08 |
| Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus Atorvastatin, Placebo - Hyperlipidemia, Diabetes Mellitus, Type 2 | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 41 | 2003-03-01 | 2021-02-18 |
Hyperlipidemias (2) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1)
Dyslipidemias (2) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Diabetes Mellitus (1)
Atorvastatin (1) · Single-Case Studies as Topic (1)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)
Canada (1) · Germany (1)